Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel.
The reversible acetylcholine esterase inhibitor (-)-physostigmine (eserine) is the prototype of a new class of nicotinic acetylcholine receptor (nAChR) activating ligands: it induces cation fluxes into nAChR-rich membrane vesicles from Torpedo marmorata electric tissue even under conditions of antagonist blocked acetylcholine binding sites (Okonjo, Kuhlmann, Maelicke, Neuron, in press). This suggests that eserine exerts its channel-activating property via binding sites at the nAChR separate from those of the natural transmitter. We now report that eserine can activate the channel even when the receptor has been preincubated (desensitized) with elevated concentrations of acetylcholine. Thus the conformational state of the receptor corresponding to desensitization is confined to the transmitter binding region, leaving the channel fully activatable-albeit only from other than the transmitter binding site(s).
Kuhlmann
J
J
Institute of Physiological Chemistry, Johannes-Gutenberg University Medical School, Mainz, Germany.
Okonjo
K O
KO
Maelicke
A
A
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002038:Bungarotoxins / Q000494:pharmacology; D002586:Cesium / Q000378:metabolism; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D014101:Torpedo
D002038:Bungarotoxins; D007473:Ion Channels; D011978:Receptors, Nicotinic; D002586:Cesium; D010830:Physostigmine; D000109:Acetylcholine